Treatment of carcinoma of the head and neck with intravenous methotrexate.
D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D007822:Laryngeal Neoplasms / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000188:drug therapy*; D010166:Palliative Care; D010610:Pharyngeal Neoplasms / Q000188:drug therapy*
D008727:Methotrexate